Skip to main content

Insulin glargine 100 [iU]/mL Medicare Part D Coverage

Brand name: BASAGLAR KwikPen KwikPen
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
1%
of Medicare Part D plans
cover Insulin glargine
49 of 5,530 plans
3.4
Avg. formulary tier

Formulary Tier Distribution

How Medicare Part D plans classify Insulin glargine. Lower tiers = lower copays.

Tier 1 - Preferred Generic 4%
2 plans • avg $0.00/mo
Tier 3 - Preferred Brand 49%
24 plans • avg $17.50/mo
Tier 4 - Non-Preferred Drug 47%
23 plans • avg $0.00/mo

Find the cheapest plan for Insulin glargine

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for Insulin glargine →

Get Insulin glargine Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

Insulin glargine Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Alternative Medications in the Same Drug Class

Other drugs in the Diabetes — Insulin that Medicare Part D plans also cover.

Frequently Asked Questions about Insulin glargine

1% of Medicare Part D plans cover Insulin glargine. It is most commonly placed on Tier 3. Coverage varies by plan and geographic area.

Costs vary by plan. Enter your ZIP code above to see exact prices for plans in your area.

Insulin glargine is placed on Tier 3 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for Insulin glargine. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Medicare & Health Management Products

Weekly AM/PM Pill Organizer
Shop on Amazon
Medication Record Keeper
Shop on Amazon
Blood Pressure Monitor
Shop on Amazon
Portable Medication Bag
Shop on Amazon

As an Amazon Associate, DrugCovered may earn from qualifying purchases. Product recommendations are for informational purposes and do not constitute medical advice.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →